Inimmune
Hybrid (Missoula, MT, USA)
About Inimmune
Inimmune is a pioneering biotech company dedicated to harnessing the innate immune system to treat and prevent disease. Our lead clinical program is a disease-modifying therapy for seasonal allergic rhinitis that targets TLR4 to reprogram the immune response against environmental allergens. Building on our expertise in immunomodulation, we are also advancing a pipeline that includes an oncology immunotherapy targeting TLR 7/8 and future clinical vaccine programs.
The Opportunity
We are seeking a Chief Medical Officer (CMO) to provide strategic and operational leadership and execution oversight of Inimmune’s innate immune focused clinical development programs, with indications in Allergy and Oncology. The ideal candidate should bring deep domain expertise in Immunology and Inflammation with experience in designing late-stage clinical trials in Allergy and Oncology preferred. Experience with vaccines and vaccine...